AutiHub

DOI work Fetched Post crossref

Suma Jacob, Jeremy Veenstra-VanderWeele, Declan Murphy, James McCracken, Janice Smith, Kevin Sanders, Christoph Meyenberg, Thomas Wiese, et al. (2022). Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial. The Lancet Psychiatry, 9(3), 199-210. Elsevier BV.

Publication date: March 2022
Identifier: 10.1016/s2215-0366(21)00429-6
Authors: Suma Jacob, Jeremy Veenstra-VanderWeele, Declan Murphy, James McCracken, Janice Smith, Kevin Sanders, Christoph Meyenberg, Thomas Wiese, Gurpreet Deol-Bhullar, Christoph Wandel, Elizabeth Ashford, Evdokia Anagnostou
Source: The Lancet Psychiatry
Details: 9(3), 199-210
Reference type: article
Publisher: Elsevier BV
Metadata source: crossref

Abstract

No abstract is available in the recovered metadata.

Study authors in this cited reference

Suma Jacob (6 other cited references)
Jeremy Veenstra-VanderWeele (20 other cited references)
Declan Murphy (29 other cited references)
James McCracken (3 other cited references)
Janice Smith (10 other cited references)
Kevin Sanders (3 other cited references)
Christoph Meyenberg (0 other cited references)
Thomas Wiese (0 other cited references)
Gurpreet Deol-Bhullar (0 other cited references)
Christoph Wandel (2 other cited references)
Elizabeth Ashford (1 other cited reference)
Evdokia Anagnostou (58 other cited references)

Open DOI Link to cited source

Post published on Twitter/X on 11 Feb 2022 06:29

Information about the link integrated into the post

1 cited resource